Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1204 N Vercler Rd
Ste201
Spokane Valley, WA 99216Phone+1 509-228-1000Fax+1 509-252-9300
Education & Training
University of Utah HealthResidency, Radiation Oncology, 2002 - 2006
Mercy Hospital (St Louis)Internship, Transitional Year, 2001 - 2002
Saint Louis University School of MedicineClass of 2001
Certifications & Licensure
ID State Medical License 2013 - 2026
WA State Medical License 2006 - 2025
UT State Medical License 2002 - 2012- American Board of Radiology Radiation Oncology
Clinical Trials
- RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE Start of enrollment: 2014 Jun 30
Publications & Presentations
PubMed
- Benefit of Avasopasem Manganese on Severe Oral Mucositis in Head and Neck Cancer in the ROMAN Trial: Unplanned Secondary Analysis.Carryn Anderson, Samuel Salvaggio, Mickaël De Backer, Jean-Christophe Chiem, Gary Walker
Advances in Radiation Oncology. 2025-01-01 - 5 citationsTwo-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurre...Carryn M Anderson, Christopher M Lee, Deborah Saunders, Amarinthia E Curtis, Neal E Dunlap
International Journal of Radiation Oncology, Biology, Physics. 2022-11-01 - 12 citationsOverall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patientsZachary C Taylor, Erin A Kaya, Jeffrey D Bunn, Zachary D Guss, Brian J Mitchell
World Journal of Clinical Oncology. 2020-12-24
Press Mentions
Understanding the Vasodilation ProcessAugust 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
